{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:49:56Z","timestamp":1778694596022,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jphs.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T15:49:48Z","timestamp":1423324188000},"page":"326-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range"],"prefix":"10.1016","volume":"127","author":[{"given":"Satoko","family":"Baba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Horisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2015.01.007_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jphs.2015.01.007_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-642-25761-2_4","article-title":"Serotonergic mechanisms as targets for existing and novel antipsychotics","volume":"212","author":"Meltzer","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00210-012-0806-3","article-title":"Dopamine D3 receptor antagonism\u2013still a therapeutic option for the treatment of schizophrenia","volume":"386","author":"Gross","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.euroneuro.2013.05.006","article-title":"The potential role of dopamine D3 receptor neurotransmission in cognition","volume":"23","author":"Nakajima","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pnpbp.2013.12.013","article-title":"Role of cerebellar dopamine D3 receptors in modulating exploratory locomotion and cataleptogenicity in rats","volume":"50","author":"Shimizu","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jphs.2015.01.007_bib6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/npp.2010.50","article-title":"The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex\u00a0vivo but not in\u00a0vitro","volume":"35","author":"McCormick","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jphs.2015.01.007_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in\u00a0vitro and in\u00a0vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacol Berl"},{"key":"10.1016\/j.jphs.2015.01.007_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuint.2011.07.002","article-title":"Cariprazine (RGH-188), a potent D3\/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in\u00a0vivo and shows antipsychotic-like and procognitive effects in rodents","volume":"59","author":"Gyerty\u00e1n","year":"2011","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jphs.2015.01.007_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.phrs.2013.01.002","article-title":"Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors","volume":"70","author":"McCormick","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jphs.2015.01.007_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/archgenpsychiatry.2009.43","article-title":"The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study with [11C]-(+)-PHNO","volume":"66","author":"Graff-Guerrero","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jphs.2015.01.007_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2011.05.005","article-title":"Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO","volume":"131","author":"Mizrahi","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jphs.2015.01.007_bib12","first-page":"845","article-title":"Dopamine-serotonin antagonist: receptor binding profile of a novel antipsychotic blonanserin","volume":"11","author":"Murasaki","year":"2008","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2015.01.007_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbr.2013.03.027","article-title":"Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism","volume":"247","author":"Horiguchi","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jphs.2015.01.007_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/jnc.12512","article-title":"Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism","volume":"128","author":"Huang","year":"2014","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.jphs.2015.01.007_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00001756-200302100-00023","article-title":"Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice","volume":"14","author":"Nagai","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.jphs.2015.01.007_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pbb.2010.04.027","article-title":"Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist","volume":"96","author":"Ohno","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jphs.2015.01.007_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2010.11.023","article-title":"Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex","volume":"653","author":"Ohoyama","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpsychires.2012.10.011","article-title":"Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials","volume":"47","author":"Kishi","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jphs.2015.01.007_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0026-895X(24)12183-9","article-title":"G\u00a0protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: a guanosine-5'-O-(3-[35S] thio)-triphosphate binding and antibody study","volume":"55","author":"Newman-Tancredi","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib21","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1016\/S0021-9258(19)39592-4","article-title":"Specificity of receptor-G protein interactions. Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system","volume":"265","author":"Senogles","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2015.01.007_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/syn.20867","article-title":"In\u00a0vitro and in\u00a0vivo comparison of [\u00b3H](+)-PHNO and [\u00b3H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D3 from D2 receptor sites","volume":"65","author":"Kiss","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.jphs.2015.01.007_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2015.01.007_bib24","first-page":"1263","article-title":"Pharmacological profile of blonanserin","volume":"10","author":"Une","year":"2007","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib25","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.89.17.8155","article-title":"Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin","volume":"89","author":"L\u00e9vesque","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jphs.2015.01.007_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0149-7634(01)00023-9","article-title":"D3 dopamine receptor, behavioral sensitization, and psychosis","volume":"25","author":"Richtand","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jphs.2015.01.007_bib27","article-title":"Cariprazine demonstrates high dopamine D3 and D2 receptor occupancy in patients with schizophrenia: a clinical PET study with [11C]-(+)-PHNO","author":"Slifstein","year":"2013","journal-title":"Am Coll Neuropsychopharmacol"},{"key":"10.1016\/j.jphs.2015.01.007_bib28","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/npp.2010.228","article-title":"In\u00a0vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO","volume":"36","author":"Girgis","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jphs.2015.01.007_bib29","article-title":"Blonanserin Ameliorates phencyclidine-induced visual-recognition memory deficits: the Complex mechanism of blonanserin action involving D3-5-HT2A and D1-NMDA receptors in the mPFC","author":"Hida","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jphs.2015.01.007_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2147\/NDT.S59861","article-title":"Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone","volume":"10","author":"Hori","year":"2014","journal-title":"J\u00a0Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jphs.2015.01.007_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hup.1276","article-title":"Effect of blonanserin on cognitive function in antipsychotic-na\u00efve first-episode schizophrenia","volume":"27","author":"Tenjin","year":"2012","journal-title":"Hum Psychopharmacol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T13:37:58Z","timestamp":1747575478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861315000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1347861315000109"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2015.01.007","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}